IGF1 and chronic obstructive pulmonary disease: The observation that IGF-I is only positively related to muscle strength when circulating levels of IL-6 is low (Barbieri et al., 2003) raises an important notion that the effectiveness of anabolic hormone therapy may be negative influenced by systemic inflammation, which is a hallmark feature of advanced COPD(Hillas et al., 2016).